HERON THERAPEUTICS, INC.: Drug Recall
Recall #D-1335-2022 · 08/02/2022
Class III: Low Risk
Recall Details
- Recall Number
- D-1335-2022
- Classification
- Class III
- Product Type
- Drug
- Recalling Firm
- HERON THERAPEUTICS, INC.
- Status
- Terminated
- Date Initiated
- 08/02/2022
- Location
- San Diego, CA, United States
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 1790 kits
Reason for Recall
Defective Delivery System: An incorrect 10 mL (12 mL) Luer (slip) syringe packaged in one lot of Zynrelef 400 mg/12 mg kit
Product Description
Zynrelef (bupivacaine and meloxicam), 400 mg bupivacaine and 12 mg meloxicam single dose application, packaged in a kit, Rx only, Manufactured for Heron Therapeutics, Inc., San Diego, CA, NDC 47426-301-02
Distribution Pattern
U.S.A. Nationwide
Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.